1/46
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Table 1 (T1)
Key potentially inappropriate drugs in pediatrics (KIDs) List: second edition
Table 2 (T2)
Excipient with know or potential harms when used in pediatric patients
Angiotensin receptor blockers (ARBs) (T1)
Agents
Azilsartan
Candesartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Risk/Rationale
Renal tubular dysgenesis
Atazanavir (T1)
Kernicterus
Camphor, topical (T1)
Seizures
Ceftriaxone (T1)
Kernicterus
Chloramphenicol (T1)
Grey baby syndrome
Chlorhexidine, topical (T1)
Chemical burn
Corticosteroids, topical (medium, high, and very high potency) (T1)
Cushing syndrome, adrenal suppression
Darunavir (T1)
Seizures, death
Dicloxacillin (T1)
Kernicterus
Recommendation: Caution in younger than 1 month
Dicyclomine (T1)
Apnea
Diphenoxylate and atropine (T1)
Respiratory failure, death
Dopamine antagonists 1st generation (T1)
Agents
Chlorpromazine
Droperidol
Fluphenazine
Haloperidol
Loxapine
Perphenazine
Pimozide
Thiothixene
Thioridazine
Trifluperazine
Prochlorperazine**
Risks/rationale
Acute dystonic reactions (e.g. oculogyric crisis, torticollis)
Hyperprolactemia** NOT in Proclorperazine
Second generation antipsychotics (T1)
Agents
Aripiprazole
Asenapine
Brexpiprazole
Cariprazine
Clozapine
Iloperisone
Lurasidone
Lumateperone
Olanzapine
Paliperidone
Quetiapine
Risperidone
Ziprasidone
Risks/rationale
Withdrawal emergent dystonia/dyskinesia
Type 2 diabetes, weight gain, dyslipidemia and/or metabolic syndrome
risk greater for clozapine >/= olanzapine > quetiapine > risperidone, paliperidone, iloperidone > asenapine > aripiprazole, brexpiprazole > lurasidone, cariprazine > ziprasidone, lumateperone
Hyperprolactemia
risk greater for paliperidone > risperidone > olanzepine
Promethazine (T1)
Risk/rationale
Respiratory failure, death
Acute dystonic reactions (e.g. oculogyric crisis, torticollis)
Recommendation
Avoid in younger than 2 yr
Caution in 2-18 yr of age
Ester local anesthetics (T1)
Benzocaine, topical
risks/rationale - methemoglobinemia
recommendation - avoid oral application in younger than 2 yr
Ester local anesthetics (T1)
Lidocaine viscous, topical
risks/rationale - CNS depression, seizures, arrythmias, death
recommendations - avoid oral application in younger than 2 yr
Gentamicin opthalamic ointment (T1)
risks/rationale - severe ocular reaction
recommendation - avoid in younger than 1 month
Linaclotide (T1)
death from dehydration
Lamotrigine (T1)
skin rashes ranging from benign to life-threatening
Loperamide (T1)
risk/rationale - Illeus, lethargy
recommendation - Avoid in younger than 3 yr for for acute infectious diarrhea
Macrolides (T1)
Agents
Azithromycin
Erythromycin
Risks/rationale
hypertrophic pyloric stenosis
risk greater for erythromycin > azithromycin
Recommendation
Avoid in younger than 1 month except for Bordetella pertussis (azithromycin) or Chlamydia trachomatis pneumonia (azithromycin and erythromycin)
Caution in younger than 1 month for Ureaplasma
Midazolam (T1)
severe intraventricular hemorrhage, periventricular leukomalacia, or death
Mineral oil (T1)
Lipid pneumonitis
Montelukast (T1)
Sleep disturbances
Caution in 18 yr of age and younger
Naloxone (T1)
Seizures
Nitrofurantoin (T1)
Hemolytic anemia
Avoid in younger than 1 month
Codeine (T1)
Respiratory failure, death
Avoid in younger than 12 yr; Avoid in 12-18 yr of age after surgery to remove tonsils and/or adenoids; Caution in 12-18 yr of age; Recommend pharmacogenetics testing
Meperidine (T1)
Acute neurotoxicity
agitation, myoclonus, hyperreflexia, tremors, delirium, seizures
Tramadol (T1)
Respiratory failure, death
Propofol (T1)
Propofol-related infusion syndrome
Avoid doses > 4 mg/kg/day for greater than 48 hr in 18 yr of age and younger
Salicylates (T1)
Agents
Aspirin
Bismuth subsalicylate
Salicylic acid (topical)
Salsalate
Risks/rationale
Reye syndrome
Rec
Caution in 18 yr of age and younger with suspicion of viral illness (influenza and varicella)
Sodium phosphate solution enema, rectal (T1)
Electrolyte abnormalities, AKI, arrythmia, death
Avoid in younger than 2 yr
Sodium polystyrene sulfonate (T1)
Colonic perforation
Sulfonmides (T1)
Agents
Silver sulfadiazine, topical
Sulfadiazine
Sulfamethoxazole
Risks/rationale
Kernicterus
Rec
Caution in younger than 1 month
Tetracyclines (T1)
Agents
Demeclocycline
Eravacycline
Minocycline
Omadacycline
Sarecycline
Tetracycline
Tigecycline
Risks/rationale
tooth discoloration
enamel hyperplasia (tetracycline)
Retardation of skeletal development and bone growth (tetracycline)
Rec
Caution in younger than 8 yr
Tricyclic antidepressants (T1)
Agents
Desipramine
Imipramine
Risks/rational
Sudden cardiac death
Rec
Avoid in 18 yr of age and younger
Valproic acid and derivatives (T1)
Pancreatitis, fatal
Verapamil (T1)
Cardiovascular collapse
Benzyl alcohol, sodium benzoate, benzoic acid (T2)
Gasping syndrome
Ethanol/ethyl alcohol (excluding ethanol lock) (T2)
CNS depression, hypoglycemia
Isopropyl alcohol, topical (T2)
Chemical burn
Methylparaben, propylparaben (T2)
Kernicterus
Phenylalanine (T2)
Cognitive and behavioral problems
Polysorbate 80 (T2)
Vasculopathic hepatotoxicity (E-ferol syndrome)
Propylene glycol
Lactic acidosis, CNS depression, hypoglycemia, hemolysis, seizure